Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this month.

FDA Approves First Fecal Transplant Pill

SER-109 is the second human feces-derived treatment to be approved by the FDA. The first was Rebyota in December of 2022.

Nejm
NEJM

C. diff is a bacterial infection that can cause severe diarrhea and inflammation of the colon, and it often recurs even after treatment with antibiotics. According to a recent LIFE-SCIENCE article, the FDA has approved the first-ever pill made from human feces for the treatment of recurrent Clostridioides difficile (C. diff) infection. The pill, called "SER-109," contains spores from multiple strains of bacteria found in healthy feces that can help restore the gut microbiome and fight off C. diff infections.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences